Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fardet

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
La Revue De Medecine Interne|January 15, 2013
[Metabolic and cardiovascular adverse events of systemic glucocorticoid therapy]L Fardet
La Revue De Medecine Interne|June 8, 2013
[Glucocorticoid-induced adverse events in patients with giant cell arteritis or polymyalgia rheumatica]L Fardet
Annales De Dermatologie Et De Venereologie|December 19, 2017
[What's new in internal medicine?]L Fardet
La Revue De Medecine Interne|March 16, 2013
[Long term glucocorticoid therapy: so much remains to be done...]L Fardet
The British Journal of Dermatology|February 10, 2017
Relative risk of and determinants for adverse events of methotrexate prescribed at a low dose: a systematic review and meta-analysis of randomized placebo-controlled trialsC Mazaud, L Fardet
Annales De Dermatologie Et De Venereologie|October 19, 2005
[Synthetic antimalarials]L Fardet, J Revuz
La Revue De Medecine Interne|January 27, 2019
[Association between prescription of long-term systemic glucocorticoid therapy associated measures and prescriber's medical speciality]M Six, C Morin, L Fardet
Clinical Epidemiology|November 16, 2017
Effects of chronic exposure of hydroxychloroquine/chloroquine on the risk of cancer, metastasis, and death: a population-based cohort study on patients with connective tissue diseasesL Fardet, I Nazareth, I Petersen
La Revue De Medecine Interne|March 23, 2011
[Description of oral glucocorticoid prescriptions in general population]L Fardet, I Petersen, I Nazareth
La Revue De Medecine Interne|January 5, 2013
[Lipodystrophies]L Fardet, C Vigouroux, J Capeau
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
La Revue De Medecine Interne|January 15, 2013
[Metabolic and cardiovascular adverse events of systemic glucocorticoid therapy]L Fardet
La Revue De Medecine Interne|June 8, 2013
[Glucocorticoid-induced adverse events in patients with giant cell arteritis or polymyalgia rheumatica]L Fardet
Annales De Dermatologie Et De Venereologie|December 19, 2017
[What's new in internal medicine?]L Fardet
La Revue De Medecine Interne|March 16, 2013
[Long term glucocorticoid therapy: so much remains to be done...]L Fardet
The British Journal of Dermatology|February 10, 2017
Relative risk of and determinants for adverse events of methotrexate prescribed at a low dose: a systematic review and meta-analysis of randomized placebo-controlled trialsC Mazaud, L Fardet
Annales De Dermatologie Et De Venereologie|October 19, 2005
[Synthetic antimalarials]L Fardet, J Revuz
La Revue De Medecine Interne|January 27, 2019
[Association between prescription of long-term systemic glucocorticoid therapy associated measures and prescriber's medical speciality]M Six, C Morin, L Fardet
Clinical Epidemiology|November 16, 2017
Effects of chronic exposure of hydroxychloroquine/chloroquine on the risk of cancer, metastasis, and death: a population-based cohort study on patients with connective tissue diseasesL Fardet, I Nazareth, I Petersen
La Revue De Medecine Interne|March 23, 2011
[Description of oral glucocorticoid prescriptions in general population]L Fardet, I Petersen, I Nazareth
La Revue De Medecine Interne|January 5, 2013
[Lipodystrophies]L Fardet, C Vigouroux, J Capeau
Pageof 6